World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 27 March 2023
Main ID:  NCT01828190
Date of registration: 08/04/2013
Prospective Registration: No
Primary sponsor: Assaf-Harofeh Medical Center
Public title: The Influence of Hyperbaric Oxygen in Patients With Perianal Crohn's Disease Already Treated With TNF Alpha Blockers Treated With TNF Alpha Blockers
Scientific title: Prospective Open-label Study of the Efficacy of the Addition of Hyperbaric Oxygen to the Treatment of Patients With Perianal Fistulas Already Treated With TNF Alpha Blockers
Date of first enrolment: March 2013
Target sample size: 50
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT01828190
Study type:  Interventional
Study design:  Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).  
Phase:  N/A
Countries of recruitment
Israel
Contacts
Name:     Haim Shirin, MD
Address: 
Telephone:
Email:
Affiliation:  Assaf Harofe Medical Center
Key inclusion & exclusion criteria

Inclusion Criteria:

patients aged 18 and above that suffer from Crohn's disease one or more perianal draining
fistulas for at least 3 months currently receiving a TNFalpha blocker for at least 3 months
(without improvement of the perianal disease)

Exclusion Criteria:

Pregnancy or plans to conceive during the next year Inability (such as previous adverse
effects, tuberculosis, concurrent infection etc.)or unwillingness to start or continue with
TNF alpha blockers treatment.

Any past or current malignancy Treatment with HBOT in the last year Claustrophobia Middle
ear problems Inability to equalize pressure in the middle ear Medical status that precludes
treatment with HBOT such as chest X-ray abnormality, epilepsy, severe congestive heart
failure, uncontrolled diabetes or uncontrolled hypertension Any perianal surgery in the
last 6 months Any change in Crohn's disease medications in the last 3 months



Age minimum: 18 Years
Age maximum: 70 Years
Gender: All
Health Condition(s) or Problem(s) studied
Perianal Fistulas
Crohn's Disease
Intervention(s)
Other: Hyperbaric oxygen
Primary Outcome(s)
Reduction of fistulas number [Time Frame: 0, 32 weeks]
Secondary Outcome(s)
Reduction of perianal symptoms [Time Frame: 0, 4, 8, 14, 20, 32]
Secondary ID(s)
HBOT- fistulas non-naive
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history